Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulcrum Therapeutics (FULC) Receivables - Net (2020 - 2022)

Historic Receivables - Net for Fulcrum Therapeutics (FULC) over the last 3 years, with Q3 2022 value amounting to $13000.0.

  • Fulcrum Therapeutics' Receivables - Net changed N/A to $13000.0 in Q3 2022 from the same period last year, while for Sep 2022 it was $13000.0, marking a year-over-year change of. This contributed to the annual value of $2.5 million for FY2021, which is 2500.0% up from last year.
  • As of Q3 2022, Fulcrum Therapeutics' Receivables - Net stood at $13000.0.
  • Fulcrum Therapeutics' Receivables - Net's 5-year high stood at $2.5 million during Q4 2021, with a 5-year trough of $13000.0 in Q3 2022.
  • For the 3-year period, Fulcrum Therapeutics' Receivables - Net averaged around $1.2 million, with its median value being $1.2 million (2020).
  • The largest annual percentage gain for Fulcrum Therapeutics' Receivables - Net in the last 5 years was 2500.0% (2021), contrasted with its biggest fall of 2500.0% (2021).
  • Over the past 3 years, Fulcrum Therapeutics' Receivables - Net (Quarter) stood at $2.0 million in 2020, then increased by 25.0% to $2.5 million in 2021, then crashed by 99.48% to $13000.0 in 2022.
  • Its last three reported values are $13000.0 in Q3 2022, $357000.0 for Q2 2022, and $2.5 million during Q4 2021.